could glp-1 be the next mental health drug Prospects of Therapies for Addiction and Comorbidities-Quo Vadis?: A Review GLP-1 Medications and Mental Health:

442 Research into ketamine actions in the CNS revealed multiple effects, including potentiation of synaptogenesis, increased density of dendritic spines and upregulation of postsynaptic levels of AMPA receptors

10.1016/j.ejphar.2013.08.045 102 ParkS.-Y.LeeY

Elsevier, Amsterdam, pp 283385 Camacho-Cristbal JJ, Herrera-Rodrguez MB, Beato VM, Rexach J, Navarro-Gochicoa MT, Maldonado JM, Gonzlez-Fontes A (2008) The expression of several cell wall-related genes in Arabidopsis roots is down-regulated under boron deficiency

These findings highlight ipamorelins potential to support bone health and combat catabolic effects on skeletal integrity (6)

10.1016/j.chemosphere.2011.04.022 Chemosphere 57 LoyallL.UchidaK.BraunS.FuruyaM.FrohnmeyerH